{"organizations": [], "uuid": "92fa61bccf67b8da20e3861945f64b8d74640f45", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180411.html", "section_title": "Archive News &amp; Video for Wednesday, 11 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-us-fda-permits-marketing-of-ai-bas/brief-u-s-fda-permits-marketing-of-ai-based-device-to-detect-certain-diabetes-related-eye-problems-idUSFWN1RO0S7", "country": "US", "domain_rank": 408, "title": "BRIEF-U.S. FDA Permits Marketing Of AI-Based Device To Detect Certain Diabetes-Related Eye Problems", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.005, "site_type": "news", "published": "2018-04-11T23:09:00.000+03:00", "replies_count": 0, "uuid": "92fa61bccf67b8da20e3861945f64b8d74640f45"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-us-fda-permits-marketing-of-ai-bas/brief-u-s-fda-permits-marketing-of-ai-based-device-to-detect-certain-diabetes-related-eye-problems-idUSFWN1RO0S7", "ord_in_thread": 0, "title": "BRIEF-U.S. FDA Permits Marketing Of AI-Based Device To Detect Certain Diabetes-Related Eye Problems", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "u.s. food and drug administration", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "idx llc", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 11 (Reuters) - U.S. Food and Drug Administration:\n* U.S. FDA PERMITS MARKETING OF FIRST MEDICAL DEVICE TO USE AI TO DETECT GREATER THAN MILD LEVEL OF THE EYE DISEASE DIABETIC RETINOPATHY IN DIABETIC ADULTS\n* U.S. FDA SAYS PERMITTING MARKETING OF IDX-DR TO IDX LLC\n* U.S. FDA SAYS THE DEVICE, CALLED IDX-DR, IS A SOFTWARE PROGRAM THAT USES AN AI ALGORITHM TO ANALYZE IMAGES OF THE EYE TAKEN WITH A RETINAL CAMERA Source text for Eikon:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-11T23:09:00.000+03:00", "crawled": "2018-04-12T14:22:48.002+03:00", "highlightTitle": ""}